Although the effect of TGFβ as a potent negative regulator of hematopoieses may contribute to tumor control, its role in leukemogenesis has been more recently associated with the findings of disruption in TGFβ signaling either by mutational inactivation or down-regulation of its components [13]. Here, TGFB1 is linked to neoplasm.